Selntigia Aikaterini, Maresca Lucia, Montanino Oliva Diletta, Coianiz Camilla, Galliano Daniela
IVIRMA Global Research Alliance, IVIRMA Roma, 00161 Rome, Italy.
Genes (Basel). 2025 Aug 20;16(8):981. doi: 10.3390/genes16080981.
Embryo selection in in vitro fertilization (IVF) aims to prioritize embryos with the highest reproductive potential. While preimplantation genetic testing for aneuploidy (PGT-A) remains the gold standard for identifying euploid embryos, it is invasive and not universally applicable. Deep learning (DL)-based models, such as the intelligent data analysis (iDA) score, have emerged as non-invasive alternatives for embryo assessment. This review critically evaluates the relationship between iDAScore (versions 1.0 and 2.0), embryo euploidy, and clinical outcomes, including live birth and miscarriage rates. A narrative review was performed using PubMed and Google Scholar, covering studies published from January 2020 to May 2025. The search included terms such as "iDAScore," "deep learning," "euploidy," and "live birth." Only English-language full-text studies assessing the predictive performance of iDAScore relative to chromosomal status or reproductive outcomes were included. Six retrospective studies met the inclusion criteria. All reported a statistically significant association between higher iDAScore values and embryo euploidy. AUC values for euploidy prediction ranged from 0.60 to 0.68. In several studies, iDAScore was also positively associated with live birth rates and negatively with miscarriage rates. However, the predictive accuracy was moderate when restricted to euploid embryo cohorts, indicating that iDAScore may be more effective in broader populations where chromosomal status is unknown. iDAScore represents a promising adjunct to traditional embryo assessment. Although it cannot replace PGT-A, it may aid in embryo prioritization when genetic testing is not feasible. Larger prospective studies are warranted to further validate its clinical utility.
体外受精(IVF)中的胚胎选择旨在优先选择具有最高生殖潜力的胚胎。虽然植入前非整倍体基因检测(PGT-A)仍然是识别整倍体胚胎的金标准,但它具有侵入性且并非普遍适用。基于深度学习(DL)的模型,如意数据分析(iDA)评分,已成为胚胎评估的非侵入性替代方法。本综述批判性地评估了iDAScore(版本1.0和2.0)、胚胎整倍体与临床结局(包括活产率和流产率)之间的关系。使用PubMed和谷歌学术进行了叙述性综述,涵盖2020年1月至2025年5月发表的研究。搜索词包括“iDAScore”、“深度学习”、“整倍体”和“活产”。仅纳入评估iDAScore相对于染色体状态或生殖结局的预测性能的英文全文研究。六项回顾性研究符合纳入标准。所有研究均报告iDAScore值越高与胚胎整倍体之间存在统计学上的显著关联。整倍体预测的AUC值范围为0.60至0.68。在几项研究中,iDAScore也与活产率呈正相关,与流产率呈负相关。然而,当仅限于整倍体胚胎队列时,预测准确性中等,这表明iDAScore在染色体状态未知的更广泛人群中可能更有效。iDAScore是传统胚胎评估的一种有前景的辅助手段。虽然它不能替代PGT-A,但在基因检测不可行时,它可能有助于胚胎的优先排序。需要进行更大规模的前瞻性研究以进一步验证其临床效用。